BridgeMD
New treatment option for Cardiac Output
Official title Short-Term Atrial Pacing and Hemodynamics After Cardiac Surgery
ClinicalTrials.gov ID: NCT07082283
What this study is testing
- What it's testing
- The goal of this clinical trial is to learn whether temporary atrial pacing improves heart function after cardiac surgery under cardiopulmonary bypass (CPB). It will also help determine the best pacing rate during the first 24 hours after surgery.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Patients aged 18 years or older
- Cardiac surgery under CPB (coronary artery bypass grafting, valve replacement or repair, or combined procedures)
- Placement of epicardial atrioventricular pacing wires during surgery
- Placement of a Swan-Ganz catheter intraoperatively
- Signed informed consent
You likely can't join if
- Emergency surgery
- Patients with an internal pacemaker
- History of permanent atrial fibrillation
- Complete atrioventricular block upon weaning from CPB
- Junctional rhythm upon weaning from CPB
- Sinus rhythm \< 50 bpm upon weaning from CPB
See the full eligibility criteria
- Patients aged 18 years or older
- Cardiac surgery under CPB (coronary artery bypass grafting, valve replacement or repair, or combined procedures)
- Placement of epicardial atrioventricular pacing wires during surgery
- Placement of a Swan-Ganz catheter intraoperatively
- Signed informed consent
- Emergency surgery
- Patients with an internal pacemaker
- History of permanent atrial fibrillation
- Complete atrioventricular block upon weaning from CPB
- Junctional rhythm upon weaning from CPB
- Sinus rhythm \< 50 bpm upon weaning from CPB
- Failure of atrial or dual-chamber pacing (patients paced in ventricular mode VVI)
- Contraindication to Swan-Ganz catheter placement
- Hemodynamic instability defined by significant bleeding or tamponade requiring surgical re-intervention, or the need for escalating doses of vasopressors (Norepinephrine \> 1 μg/kg/min, Dobutamine \> 10 μg/kg/min)
The study team makes the final eligibility decision.
Where it's taking place
- Beirut, Lebanon
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Beirut, Lebanon. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.